Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26202
Title: Associations between preoperative anaemia and hospital costs following major abdominal surgery: cohort study.
Austin Authors: Meyerov, J;Louis, Maleck ;Lee, D K;Fletcher, L;Banyasz, D;Miles, Lachlan F ;Ma, Ronald ;Tosif, Shervin ;Koshy, Anoop N ;Story, David A ;Bellomo, Rinaldo ;Weinberg, Laurence 
Affiliation: Business Intelligence
Anaesthesia
Surgery (University of Melbourne)
Cardiology
Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia
Intensive Care
Data Analytics Research and Evaluation (DARE) Centre
Department of Anaesthesiology and Pain Medicine, Korea University Guro Hospital, Guro-Gu, Seoul, South Korea
Issue Date: 5-Mar-2021
metadata.dc.date: 2021-03-05
Publication information: BJS Open 2021; 5(2): zraa070
Abstract: Determining the cost-effectiveness and sustainability of patient blood management programmes relies on quantifying the economic burden of preoperative anaemia. This retrospective cohort study aimed to evaluate the hospital costs attributable to preoperative anaemia in patients undergoing major abdominal surgery. Patients who underwent major abdominal surgery between 2010 and 2018 were included. The association between preoperative patient haemoglobin (Hb) concentration and hospital costs was evaluated by curve estimation based on the least-square method. The in-hospital cost of index admission was calculated using an activity-based costing methodology. Multivariable regression analysis and propensity score matching were used to estimate the effects of Hb concentration on variables related directly to hospital costs. A total of 1286 patients were included. The median overall cost was US $18 476 (i.q.r.13 784-27 880), and 568 patients (44.2 per cent) had a Hb level below 13.0 g/dl. Patients with a preoperative Hb level below 9.0 g/dl had total hospital costs that were 50.6 (95 per cent c.i. 14.1 to 98.9) per cent higher than those for patients with a preoperative Hb level of 9.0-13.0 g/dl (P < 0.001), 72.5 (30.6 to 128.0) per cent higher than costs for patients with a Hb concentration of 13.1-15.0 g/dl (P < 0.001), and 62.4 (21.8 to 116.7) per cent higher than those for patients with a Hb level greater than 15.0 g/dl (P < 0.001). Multivariable general linear modelling showed that packed red blood cell (PRBC) transfusions were a principal cost driver in patients with a Hb concentration below 9.0 g/dl. Patients with the lowest Hb concentration incurred the highest hospital costs, which were strongly associated with increased PRBC transfusions. Costs and possible complications may be decreased by treating preoperative anaemia, particularly more severe anaemia.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26202
DOI: 10.1093/bjsopen/zraa070
PubMed URL: 33834189
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on Jun 19, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.